Similarly, CD4+ T cells were immunized with OVA-Dex, and exosomes derived from the immunized CD4+ T cells stimulated a long-term, OVA-specific CD8+ T cell memory response, and immunity against melanoma cells in vitro and in vivo [100]. Here, CD8A is linked to melanoma.